Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06094426 | Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors | terminated | Early Phase 1 | 2 | Grit BiotechnologyINDUSTRY | 1 | Apr 29, 2026 | clinicaltrials |
| NCT07108140 | Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors | terminated | Early Phase 1 | 5 | TCRCure Biopharma Ltd.INDUSTRY | 1 | Jan 22, 2026 | clinicaltrials |
| NCT03579446 |
| Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer |
| terminated |
| Early Phase 1 |
| 43 |
| M.D. Anderson Cancer CenterOTHER |
| 1 |
| Aug 3, 2025 |
| clinicaltrials |
| NCT04237649 | KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors | terminated | Early Phase 1 | 77 | Novartis PharmaceuticalsINDUSTRY | 8 | May 18, 2025 | clinicaltrials |
| NCT03514121 | FPA150 in Patients With Advanced Solid Tumors(FPA150-001) | terminated | Early Phase 1 | 95 | Five Prime Therapeutics, Inc.INDUSTRY | 2 | Nov 22, 2024 | clinicaltrials |
| NCT05271279 | A Study of OVV-01 Injection in Combination With IBR900 Cell Injection in Patients With Advanced Malignant Tumors | terminated | Early Phase 1 | 2 | Beijing Boren HospitalOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT02653196 | A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors | terminated | Early Phase 1 | 1 | Montefiore Medical CenterOTHER | 1 | Aug 17, 2017 | clinicaltrials |
| NCT01632696 | Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors | terminated | Early Phase 1 | 11 | Peregrine PharmaceuticalsINDUSTRY | 1 | Jul 11, 2017 | clinicaltrials |
| NCT00253461 | 11C Topotecan PET Imaging | terminated | Early Phase 1 | 7 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Apr 29, 2026source: clinicaltrials